Korean Drug Co. Ltd (014570) - Total Liabilities

Latest as of September 2025: ₩14.01 Billion KRW ≈ $9.50 Million USD

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has total liabilities worth ₩14.01 Billion KRW (≈ $9.50 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Korean Drug Co. Ltd to assess how effectively this company generates cash.

Korean Drug Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Korean Drug Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Korean Drug Co. Ltd (014570) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Korean Drug Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Korean Drug Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Italy Innovazioni SpA PA:MLITN	France	€919.76K
Alam Maritim Resources Bhd KLSE:5115	Malaysia	RM170.84 Million
DS Sigma Holdings Berhad KLSE:0269	Malaysia	RM14.35 Million
Asuransi Harta Aman Pratama Tbk PT JK:AHAP	Indonesia	Rp968.67 Billion
Qingdao Hengshun Zhongsheng SHE:300208	China	CN¥2.41 Billion
Katapult Holdings Inc NASDAQ:KPLT	USA	$144.31 Million
Nordic Iron Ore ST:NIO	Sweden	Skr17.16 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Korean Drug Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 014570 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Korean Drug Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Korean Drug Co. Ltd (2014–2024)

The table below shows the annual total liabilities of Korean Drug Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩10.78 Billion ≈ $7.31 Million	-14.56%
2023-12-31	₩12.62 Billion ≈ $8.55 Million	+28.72%
2022-12-31	₩9.80 Billion ≈ $6.64 Million	-17.77%
2021-12-31	₩11.92 Billion ≈ $8.08 Million	-4.42%
2020-12-31	₩12.47 Billion ≈ $8.45 Million	+15.50%
2019-12-31	₩10.80 Billion ≈ $7.32 Million	+6.27%
2018-12-31	₩10.16 Billion ≈ $6.89 Million	+3.48%
2017-12-31	₩9.82 Billion ≈ $6.66 Million	+0.73%
2016-12-31	₩9.75 Billion ≈ $6.61 Million	+2.42%
2015-12-31	₩9.52 Billion ≈ $6.45 Million	-28.88%
2014-12-31	₩13.38 Billion ≈ $9.07 Million	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$30.72 Million

₩45.33 Billion KRW

Market Cap Rank

#23642 Global

#1699 in Korea

Share Price

₩4190.00

Change (1 day)

-1.30%

52-Week Range

₩3765.00 - ₩4975.00

All Time High

₩13030.58